Metraipolis › archive › dc_daf71e327b06
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques — Europe PMC PMID:34283885
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34283885
- DOI
- 10.1371/journal.ppat.1009738
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-03T14:18:55.803Z
- SHA-256 of the archived text
a784bafdc6bd8e3174eb0eb9b531247a2faa40cc6fc3faa5fb897aae0bdd447c- Stable URL of this page
https://metraipolis.com/documento/dc_daf71e327b06
How to cite
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques — Europe PMC PMID:34283885 — Europe PMC (en), https://europepmc.org/article/MED/34283885 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_daf71e327b06 (Metraipolis archive dc_daf71e327b06, sha256 a784bafdc6bd8e3174eb0eb9b531247a2faa40cc6fc3faa5fb897aae0bdd447c)
BibTeX
@misc{dcdaf71e327b06,
title = {Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques — Europe PMC PMID:34283885},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34283885},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_daf71e327b06; sha256 a784bafdc6bd8e3174eb0eb9b531247a2faa40cc6fc3faa5fb897aae0bdd447c},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34283885. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Broadly neutralizing antibodies (bNAbs) directed to HIV-1 have shown promise at suppressing viremia in animal models. However, the use of bNAbs for the central nervous system (CNS) infection is confounded by poor penetration of the blood brain barrier (BBB). Typically, antibody concentrations in the CNS are extremely low; with levels in cerebrospinal fluid (CSF) only 0.1% of blood concentrations. Using a novel nanotechnology platform, which we term nanocapsules, we show effective transportation of the human bNAb PGT121 across the BBB in infant rhesus macaques upon systemic administration up to 1.6% of plasma concentration. We demonstrate that a single dose of PGT121 encased in nanocapsules when delivered at 48h post-infection delays early acute infection with SHIVSF162P3 in infants, with one of four animals demonstrating viral clearance. Importantly, the nanocapsule delivery of PGT121 improves suppression of SHIV infection in the CNS relative to controls. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2021 (prima pubblicazione 2021-07-20). Identificativi: PMID 34283885 · PMCID PMC8323878 · DOI 10.1371/journal.ppat.1009738. Pagina: https://europepmc.org/article/MED/34283885 — https://doi.org/10.1371/journal.ppat.1009738. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-03T14:09:34.755Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.